Robot surgery could spare young men from chemo side effects
NCT ID NCT06144736
Summary
This study is testing whether robot-assisted surgery can help predict which testicular cancer patients need chemotherapy and which don't. Researchers will perform the surgery on 60 men with early-stage metastatic seminoma, then use clinical and molecular factors to estimate recurrence risk. The goal is to help about 70% of patients avoid chemotherapy's long-term side effects while maintaining excellent survival rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEMINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Duesseldorf
RECRUITINGDüsseldorf, Germany
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.